Laser vs Hyaluronic Acid for GSM in Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Urogenital Disease
Interventions
DEVICE

Cikatridina

Women are asked to insert the suppositories according to the manufacturer's protocol.

DEVICE

Juliet Feminine Laser

Women will receive the laser treatment twice during the study period.

Trial Locations (1)

8045

RECRUITING

Department of Obstetrics, Medical University Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER